Therapex
PrivateTotal Funding Raised
$8.73M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Therapex is a biotechnology company that develops small molecule-based anti-cancer drugs and precision medicines for patients with drug-resistant tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Therapex Comparables
Compare Therapex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| J INTS BIO | 94% | |
| Black Diamond Therapeutics | 78% | |
| ArriVent | 76% | |
Therapex Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 84% MoM, reaching 1.6K.
- Jan 20, 2026
Monthly visitors increased 201% MoM, reaching 4.1K.
Therapex Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Therapex's valuation, stock price, and market status.